Which Companies Are In Michael King’s Oncology Wheelhouse?

By Life Sciences Report JMP Securities Managing Director and Senior Biotechnology Analyst Michael King Jr. never recoils from the most sophisticated science. He’s always been ...

Trader thinks Jazz may hit sour note

By Mike Yamamoto Jazz Pharmaceuticals drew bearish option activity on Friday as its shares pulled back from a month-long rally. optionMONSTER’s Depth Charge system detected the ...

3 Biotech Growth Stocks Near Highs

By ONeil Trader You can always find growth opportunities in the biotech sector. I have picked out three biotech stocks with solid fundamentals, compelling growth and prices near all-time ...

3 Humongous Health-Care Stocks This Week

By Keith Speights Every week we answer the pressing question on the minds of millions: “Which health-care stocks were the biggest winners over the past five days?” All ...

J&J’s Prostate Cancer Drug Zytiga Approved for Earlier Use in EU

By Brian Orelli On Friday, Johnson & Johnson‘s (NYSE: JNJ  ) Zytigareceived an expanded approval from the European Commission. The drug was previously approved for patients ...

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

By Brian Orelli The 10-5 vote by a Food and Drug Administration advisory committee recommending approval of Johnson & Johnson‘s (NYSE: JNJ  ) diabetes drug canagliflozin ...

AbbVie recalling thyroid drug

Abbot Lab spinoff issues second drug recall involving thyroid drug Synthroid By The Associated Press AbbVie Inc., an Abbott Laboratories spin-off, has recalled more than 28,520 bottles ...

Man Taking Generic Drug Can Sue Branded Maker

By KATIE THOMAS The Alabama Supreme Court ruled on Friday that a patient could sue a brand-name company for failing to warn about a drug’s risks even though he had taken a generic ...

1 Great Dividend You Can Buy Right Now

By Sean Williams Dividend stocks are everywhere, but many just downrightstink. In some cases, the business model is in serious jeopardy, or the dividend itself isn’t sustainable. ...

Sleeping Pill Doses Are Cut for Women

By Anna Edney & Catherine Larkin Makers of widely used sleep aids such as Sanofi (SAN)’s Ambien have been told to reduce by half the recommended doses for women after U.S. ...

JPMorgan Healthcare Conference Highlights: MannKind

By Sean Williams The JPMorgan Healthcare Conference just finished up in San Francisco and was arguably the most important event of the entire year for the health care sector. This ...

Merck begins overseas recall of HDL cholesterol drug

(Reuters) – Merck & Co said it is recalling Tredaptive, its medicine to raise “good” HDL cholesterol levels, in overseas markets where it is sold, after it failed ...
Page 1 of 7212345...102030...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS